Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
Journal of Surgical Oncology
|
October 12, 2000
Surgical management of epithelial ovarian cancer at community hospitals: A population-based study
P Petignat, D Vajda, F Joris, et al.
Deutsche Medizinische Wochenschrift (1946)
|
February 21, 1986
[The use of paramedical treatment methods by cancer patients. A inquiry on 101 ambulatory patients]
R Obrist, M von Meiss, J P Obrecht
Schweizerische Medizinische Wochenschrift
|
September 7, 1985
[Autoimmune thrombocytopenic purpura in malignant lymphoma. Report of 2 cases and review of the literature]
R Obrist, C Ludwig, J Klüppelberg, et al.
Journal of Cellular Biochemistry
|
December 1, 1991
Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages
R Landmann, C Ludwig, R Obrist, et al.
Cancer Research
|
January 1, 1983
Enhanced arachidonic acid lipoxygenation by K562 cells stimulated with 12-O-tetradecanoylphorbol-13-acetate
F H Valone, R Obrist, N Tarlin, et al.
Molecular Immunology
|
January 1, 1991
Human B cells express membrane-bound and soluble forms of the CD14 myeloid antigen
M O Labeta, R Landmann, J P Obrecht, et al.
Schweizerische Medizinische Wochenschrift
|
March 7, 1998
[Ovarian cancer: the symptoms and pathology. The cases of the Cantonal Cancer Registry (1989-1995)]
P Petignat, G Gaudin, D Vajda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1990
Localized skin toxicity from 5-fluorouracil after paravenous infusion of leukovorin calcium
R Obrist, S T Haenggi, D Heiman, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1985
Chemotactic anti-tumor antibodies: in vitro results with four different antibody preparations
R Obrist, J P Obrecht, R C Bast, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1991
Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trial
R Obrist, J Schmidli, R Müller, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
Journal of Surgical Oncology
|
October 12, 2000
Surgical management of epithelial ovarian cancer at community hospitals: A population-based study
P Petignat, D Vajda, F Joris, et al.
Deutsche Medizinische Wochenschrift (1946)
|
February 21, 1986
[The use of paramedical treatment methods by cancer patients. A inquiry on 101 ambulatory patients]
R Obrist, M von Meiss, J P Obrecht
Schweizerische Medizinische Wochenschrift
|
September 7, 1985
[Autoimmune thrombocytopenic purpura in malignant lymphoma. Report of 2 cases and review of the literature]
R Obrist, C Ludwig, J Klüppelberg, et al.
Journal of Cellular Biochemistry
|
December 1, 1991
Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages
R Landmann, C Ludwig, R Obrist, et al.
Cancer Research
|
January 1, 1983
Enhanced arachidonic acid lipoxygenation by K562 cells stimulated with 12-O-tetradecanoylphorbol-13-acetate
F H Valone, R Obrist, N Tarlin, et al.
Molecular Immunology
|
January 1, 1991
Human B cells express membrane-bound and soluble forms of the CD14 myeloid antigen
M O Labeta, R Landmann, J P Obrecht, et al.
Schweizerische Medizinische Wochenschrift
|
March 7, 1998
[Ovarian cancer: the symptoms and pathology. The cases of the Cantonal Cancer Registry (1989-1995)]
P Petignat, G Gaudin, D Vajda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1990
Localized skin toxicity from 5-fluorouracil after paravenous infusion of leukovorin calcium
R Obrist, S T Haenggi, D Heiman, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1985
Chemotactic anti-tumor antibodies: in vitro results with four different antibody preparations
R Obrist, J P Obrecht, R C Bast, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1991
Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trial
R Obrist, J Schmidli, R Müller, et al.
Page
of 7